These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32920591)

  • 1. Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB).
    Yan F; Wu Z; Li Z; Liu L
    Med Sci Monit; 2020 Sep; 26():e922814. PubMed ID: 32920591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
    Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
    Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation.
    Ni H; Zhao W; Kong X; Li H; Ouyang J
    Acta Haematol; 2014; 131(2):102-11. PubMed ID: 24157922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells.
    Li H; Li Y; Liu D; Sun H; Liu J
    Cell Physiol Biochem; 2013; 32(2):448-58. PubMed ID: 23988648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celastrol inhibits breast cancer cell invasion via suppression of NF-ĸB-mediated matrix metalloproteinase-9 expression.
    Kim Y; Kang H; Jang SW; Ko J
    Cell Physiol Biochem; 2011; 28(2):175-84. PubMed ID: 21865725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol inhibits interleukin-17A-stimulated rheumatoid fibroblast-like synoviocyte migration and invasion through suppression of NF-κB-mediated matrix metalloproteinase-9 expression.
    Li GQ; Zhang Y; Liu D; Qian YY; Zhang H; Guo SY; Sunagawa M; Hisamitsu T; Liu YQ
    Int Immunopharmacol; 2012 Dec; 14(4):422-31. PubMed ID: 22954486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
    Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
    Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells via Downregulating NF-κB/COX-2 Signaling Pathways.
    Zhang H; Zhao X; Shang F; Sun H; Zheng X; Zhu J
    Anticancer Agents Med Chem; 2022; 22(10):1921-1932. PubMed ID: 34732120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of lupeol on migration and invasion of human breast cancer MDA-MB-231 cells and its mechanism].
    Wang M; Cui HX; Sun C; Li G; Wang HL; Xia CH; Wang YC; Liu JC
    Yao Xue Xue Bao; 2016 Apr; 51(4):558-62. PubMed ID: 29859524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer.
    Song L; Chen X; Mi L; Liu C; Zhu S; Yang T; Luo X; Zhang Q; Lu H; Liang X
    Cancer Sci; 2020 Nov; 111(11):4242-4256. PubMed ID: 32926492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
    Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
    Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway.
    Cheng X; Gu J; Zhang M; Yuan J; Zhao B; Jiang J; Jia X
    Int Immunopharmacol; 2014 Nov; 23(1):304-13. PubMed ID: 25218161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celastrol blocks interleukin-6 gene expression via downregulation of NF-κB in prostate carcinoma cells.
    Chiang KC; Tsui KH; Chung LC; Yeh CN; Chen WT; Chang PL; Juang HH
    PLoS One; 2014; 9(3):e93151. PubMed ID: 24664372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
    Sethi G; Ahn KS; Pandey MK; Aggarwal BB
    Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Puerarin suppresses LPS-induced breast cancer cell migration, invasion and adhesion by blockage NF-κB and Erk pathway.
    Liu X; Zhao W; Wang W; Lin S; Yang L
    Biomed Pharmacother; 2017 Aug; 92():429-436. PubMed ID: 28558356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celastrol inhibits the migration and invasion and enhances the anti-cancer effects of docetaxel in human triple-negative breast cancer cells.
    Liu Z; Fan M; Xuan X; Xia C; Huang G; Ma L
    Med Oncol; 2022 Sep; 39(12):189. PubMed ID: 36071249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3.
    Zhang B; Shetti D; Fan C; Wei K
    Biol Res; 2019 Jul; 52(1):38. PubMed ID: 31349873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.
    Maroufi NF; Vahedian V; Akbarzadeh M; Mohammadian M; Zahedi M; Isazadeh A; Pouremamali F; Taefehshokr S; Heidari M; Rashidi M; Nouri M
    Breast Cancer; 2020 Jul; 27(4):613-620. PubMed ID: 32026267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.